Peptide mimics of monocyte chemoattractant protein-1 (MCP-1) with an antagonistic activity

Journal of Biochemistry

Volumn 129, Issue 4, 2001, Pages 577-583

  Kaji, Masatomo ^a,b   Ikari, Masaomi ^a   Hashiguchi, Shuhei ^a   Ito, Yuji ^a   Matsumoto, Ryo ^a   Yoshimura, Teizo ^c   Kuratsu, Jun Ichi ^b   Sugimura, Kazuhisa ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Inhibition; MCP 1; Molecular design; Peptide mimic; Phage library

Indexed keywords

CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; PEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CHEMOTAXIS; DNA SEQUENCE; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; MONOCYTE; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

EID: 0035053756     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jbchem.a002893     Document Type: Article

References (25)

1. Peptide mimics of the CTLA4-binding domain stimulate T-cell proliferation
2. T cell proliferation-augmenting activities of the gene 3 protein derived from a phage library clone with CD80-binding activity
3. Inhibition of M-tropic HIV-1 infection by the fd phage-gene 3 protein with MIP-1α-binding activity
4. Production and characterization of human glioma cell-derived monocyte chemotactic factor
5. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants
6. Chemokines: A new classification system and their role in immunity
7. Human monocyte chemoattractant protein-1: Structure and function
8. Chemokines - Chemotactic cytokines that mediate inflammation
9. 15N) NMR assignments and solution structure of the monocyte chemoattractant protein-1 (MCP-1) dimer
10. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis
11. Monocyte chemoattractant protein-1 in human atheromatous plaques
12. Monocyte chemoattractant protein inhibits the generation of tumor-reactive T cells
13. Chemokines
14. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody
15. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions
16. Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium
17. Production and characterization of mouse monoclonal antibodies against human monocyte chemoattractant protein-1
18. Site-directed mutagenesis of monocyte chemoattractant protein-1 identifies two regions of the polypeptide essential for biological activity
19. 2-terminal residues
20. The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation
21. The amino-terminal domain of CCR2 is both necessary and sufficient for high affinity binding of monocyte chemoattractant protein 1. Receptor activation by a pseudo-tethered ligand
22. Mapping of MCP-1 functional domains by peptide analysis and site-directed mutagenesis
23. Structure/activity analysis of human monocyte chemoattractant protein-1 (MCP-1) by mutagenesis. Identification of a mutated protein that inhibits MCP-1-mediated monocyte chemotaxis
24. Identification of C-C chemokine receptor 1 (CCR1) as the monocyte hemofiltrate C-C chemokine (HCC)-1 receptor